J Sode

Years Active: 2014-2017
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

S Bank, Paal Skytt Andersen, J Burisch, N Pedersen, S Roug, J Galsgaard, S Y Turino, J B Brodersen, S Rashid, B K Rasmussen, S Avlund, T B Olesen, H J Hoffmann, B A Nexø, J Sode, U Vogel, V Andersen
Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy. The pharmacogenomics journal 18 (1) (2017)
J Sode, U Vogel, S Bank, P S Andersen, M L Hetland, H Locht, N H H Heegaard, V Andersen
Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis. The pharmacogenomics journal 18 (1) (2016)
S Bank, P S Andersen, J Burisch, N Pedersen, S Roug, J Galsgaard, S Y Turino, J B Brodersen, S Rashid, B K Rasmussen, S Avlund, T B Olesen, H J Hoffmann, M K Thomsen, V Ø Thomsen, M Frydenberg, B A Nexø, J Sode, U Vogel, V Andersen
Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease. The pharmacogenomics journal 14 (6) (2014)

J Sode.css-eqlu8i{font-size:small;padding-left:4px;}